Psoriasis Clinical Trial

A Study to Investigate Efficacy and Safety of KBL697 in Patients With Moderate Plaque Type Psoriasis

Summary

The study is designed to investigate efficacy and safety of KBL697 in patients with Moderate Plaque Type Psoriasis. KBL697 has been developed as a potential new treatment for Psoriatic Plaque.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male or female, aged 18 to 75 years (inclusive)
Have a diagnosis of plaque type psoriasis for ≥ 6 months
Must have chronic plaque type psoriasis of moderate severity
All subjects must agree and commit to the use of a reliable contraceptive regimen.

Exclusion Criteria:

Current diagnosis of forms of psoriasis other than chronic plaque type only
Drug-induced psoriasis
Other inflammatory skin disease that may confound the evaluation of plaque psoriasis
Failed 2 or more systemic treatments for plaque psoriasis
Medicinal shampoos that contain tar and/or salicylic acid within 2 weeks prior to Baseline Visit

Study is for people with:

Psoriasis

Phase:

Phase 2

Estimated Enrollment:

80

Study ID:

NCT04911751

Recruitment Status:

Active, not recruiting

Sponsor:

KoBioLabs

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 10 Locations for this study

See Locations Near You

Total Skin and Beauty Dermatology Center
Birmingham Alabama, 35205, United States
Southern California Dermatology, Inc
Santa Ana California, 92701, United States
Clinical Science Institute
Santa Monica California, 90404, United States
Revival Research Institute
Doral Florida, 33122, United States
Indago Research and Health Center
Hialeah Florida, 33012, United States
Louisiana Dermatology Associates - Dermatology
Baton Rouge Louisiana, 70809, United States
Premier Specialist
Kogarah New South Wales, 2217, Australia
Westmead Hospital
Westmead New South Wales, 2145, Australia
Veracity Clinical Trials Ltd
Woolloongabba Queensland, 4102, Australia
Sinclair Dermatology
East Melbourne Victoria, 3002, Australia

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 2

Estimated Enrollment:

80

Study ID:

NCT04911751

Recruitment Status:

Active, not recruiting

Sponsor:


KoBioLabs

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.